Benjamin Edwards Inc Seres Therapeutics, Inc. Transaction History

Benjamin Edwards Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$5.46 - $22.6 $3,707 - $15,345	-679 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$18.46 - $24.36 $4,116 - $5,432	-223 Reduced 24.72%	679 $16,000
Q1 2021 May 14, 2021	BUY	$17.66 - $28.92 $229 - $375	13 Added 1.46%	902 $19,000
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $6,742 - $10,941	-290 Reduced 24.6%	889 $22,000
Q3 2020 Nov 16, 2020	SELL	$3.74 - $28.74 $579 - $4,454	-155 Reduced 11.62%	1,179 $33,000
Q1 2020 May 07, 2020	BUY	$2.64 - $3.82 $139 - $202	53 Added 4.14%	1,334 $5,000
Q4 2019 Feb 06, 2020	BUY	$2.99 - $4.42 $188 - $278	63 Added 5.17%	1,281 $4,000
Q3 2019 Nov 05, 2019	SELL	$2.29 - $4.16 $164 - $299	-72 Reduced 5.58%	1,218 $5,000
Q2 2019 Aug 08, 2019	BUY	$2.28 - $7.35 $1,347 - $4,343	591 Added 84.55%	1,290 $4,000
Q1 2019 May 15, 2019	BUY	$4.83 - $7.21 $3,376 - $5,039	699 New	699 $5,000

40.9M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $104M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

Stay updated on Benjamin Edwards Inc with notifications on news.